Moreover, the active constituent of AMD specifically targets aromatase and does not inhibit the activity of the 5α-reductase enzyme, which has the same substrate "testosterone." These findings suggest the potential specificity of AMD as an aromatase inhibitor (Luo et al. 2023). The gene discussed is CYP19A1; the disease is age-related macular degeneration.